New England Journal of Medicine· 2012Q1
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
- 560citations
- Q1SCImago
- 2012year
Short summary
Low-dose aspirin (100 mg daily) did not significantly reduce recurrent venous thromboembolism (VTE) but did significantly reduce major vascular events by 34% (HR 0.66) and overall major vascular events or death by 33% (HR 0.67) in patients who completed initial anticoagulant therapy for unprovoked VTE.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine